Assenagon Asset Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.7M Sell
693,635
-1,025,614
-60% -$68.3M 0.06% 241
2026
Q1
$108M Buy
1,719,249
+492,800
+40% +$34.3M 0.16% 104
2025
Q4
$81.4M Buy
1,226,449
+397,690
+48% +$25.7M 0.11% 151
2025
Q3
$55.8M Sell
828,759
-379,496
-31% -$30M 0.08% 203
2025
Q2
$105M Buy
1,208,255
+557,576
+86% +$43.7M 0.16% 134
2025
Q1
$44.4M Buy
650,679
+3,833
+0.6% +$313K 0.07% 227
2024
Q4
$50.3M Sell
646,846
-342,894
-35% -$25.4M 0.08% 203
2024
Q3
$66.4M Buy
989,740
+345,114
+54% +$28.3M 0.12% 144
2024
Q2
$73.1M Buy
644,626
+216,545
+51% +$27.4M 0.16% 106
2024
Q1
$59.4M Buy
428,081
+310,565
+264% +$39M 0.14% 112
2023
Q4
$14.6M Sell
117,516
-267,779
-69% -$27.4M 0.04% 364
2023
Q3
$35.9M Buy
385,295
+353,901
+1,127% +$39.9M 0.11% 166
2023
Q2
$4.03M Buy
31,394
+19,764
+170% +$2.39M 0.01% 556
2023
Q1
$1.35M Sell
11,630
-42,724
-79% -$4.78M ﹤0.01% 958
2022
Q4
$6.16M Sell
54,354
-668
-1% -$73.3K 0.02% 494
2022
Q3
$4.43M Buy
55,022
+49,569
+909% +$4.2M 0.02% 514
2022
Q2
$406K Sell
5,453
-133,139
-96% -$12.2M ﹤0.01% 1264
2022
Q1
$17.7M Sell
138,592
-103,172
-43% -$11.3M 0.05% 256
2021
Q4
$32.5M Buy
241,764
+199,852
+477% +$28.7M 0.09% 148
2021
Q3
$5.73M Sell
41,912
-69,296
-62% -$8.74M 0.02% 395
2021
Q2
$11.9M Sell
111,208
-124,852
-53% -$12M 0.04% 312
2021
Q1
$21.2M Buy
236,060
+173,740
+279% +$16.3M 0.09% 205
2020
Q4
$5.76M Buy
+62,320
New +$5.56M 0.03% 336
2020
Q3
Sell
-8,164
Closed -$827K 1180
2020
Q2
$827K Buy
8,164
+952
+13% +$85.2K 0.01% 869
2020
Q1
$485K Sell
7,212
-14,068
-66% -$875K ﹤0.01% 647
2019
Q4
$1.16M Buy
+21,280
New +$1.01M 0.01% 552

Other funds holding DXCM

Assenagon Asset Management's DXCM Position: Q2 2026 in Review

Assenagon Asset Management reduced its DexCom (DXCM) stake by 60% in Q2 2026, selling an estimated $68.3M and leaving 693,635 shares worth $46.7M. The position accounts for 0.06% of the portfolio, ranked #241.

Assenagon Asset Management first reported a position in DXCM in Q4 2019 and has held it in 26 quarters since. The position peaked at $108M in Q1 2026. 158 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Assenagon Asset Management held 693,635 shares of DexCom worth $46.7M as of Q2 2026.
  • Assenagon Asset Management sold 1,025,614 DexCom shares in Q2 2026, an estimated $68.3M.
  • DexCom made up 0.06% of Assenagon Asset Management's portfolio in Q2 2026, its #241 holding.
  • Assenagon Asset Management first reported a position in DexCom in Q4 2019 and has held it in 26 quarters since.
  • Assenagon Asset Management's DexCom position peaked at $108M in Q1 2026.
  • 158 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.